Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Rang in Aktien #18
Johnson & Johnson, together with its subsidiaries, researches and develops,... Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Aktienkurs
$240.45
Marktkapitalisierung
$579.46B
Veränderung (1 Tag)
0.51%
Veränderung (1 Jahr)
46.88%
Land
US
Handel Johnson & Johnson (JNJ)

Kategorie

EPS für Johnson & Johnson (JNJ)
EPS zum December 2025 TTM: $11.10
Laut den aktuellen Finanzberichten und dem Aktienkurs von Johnson & Johnson beträgt das aktuelle EPS des Unternehmens (TTM) $11.10. Am Ende des Jahres 2024 betrug das EPS $5.84 eine Steigerung gegenüber dem EPS von 2023, das $13.88 betrug.
EPS-Verlauf von Johnson & Johnson von 2000 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $11.10 0.63%
2025 $11.03 88.87%
2024 $5.84 -57.93%
2023 $13.88 75.03%
2022 $7.93 41.86%
2021 $5.59 -2.61%
2019 $5.74 -0.17%
2018 $5.75 1,097.92%
2017 $0.48 -92.11%
2016 $6.08 9.16%
2015 $5.57 -4.95%
2014 $5.86 19.59%
2013 $4.90 25.32%
2012 $3.91 10.45%
2011 $3.54 -27.16%
2010 $4.86 9.21%
2009 $4.45 -4.71%
2008 $4.67 27.25%
2007 $3.67 -2.39%
2006 $3.76 11.24%
2005 $3.38 22.91%
2004 $2.75 13.64%
2003 $2.42 10.00%
2002 $2.20 17.65%
2001 $1.87 13.33%
2000 $1.65 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$23.00 107.21%
US
$2.37 -78.65%
US
$7.20 -35.14%
CH
$13.20 18.92%
GB
$7.30 -34.23%
US